Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Shanghai MicroPort MedBot (Group) Co., Ltd. Class H ( (HK:2252) ) is now available.
Shanghai MicroPort MedBot (Group) Co., Ltd. announced the convening of its Annual General Meeting on June 25, 2025, to discuss and approve several key resolutions. These include the approval of the 2024 Annual Report, the appointment of new directors and auditors, and the granting of mandates to issue additional shares and buy back shares. These resolutions are expected to impact the company’s capital structure and operational strategies, potentially influencing its market positioning and shareholder value.
The most recent analyst rating on (HK:2252) stock is a Buy with a HK$9.50 price target. To see the full list of analyst forecasts on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H stock, see the HK:2252 Stock Forecast page.
More about Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
Shanghai MicroPort MedBot (Group) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, focusing on the medical technology industry. The company is involved in the development and manufacturing of medical robots and related technologies, aiming to enhance surgical precision and efficiency.
Average Trading Volume: 9,619,595
Technical Sentiment Signal: Buy
Current Market Cap: HK$16.05B
Find detailed analytics on 2252 stock on TipRanks’ Stock Analysis page.